AMPHASTAR PHARMACEUTICALS IN - NOTE 2.000% 3/1 Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2024 to Q4 2025

Type / Class
Debt / NOTE 2.000% 3/1
Market price (% of par)
92.58%
All holders as of 30 Sep 2025
Q3 2025
Total 13F principal
$298,658,206
Total reported market value
$271,682,316
Principal change
+$16,654,006
Market value change
+$15,400,429
Number of holders
44
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

As of 30 Sep 2025, 44 institutional investors reported holding $298,658,206 in principal (par value) of AMPHASTAR PHARMACEUTICALS IN - NOTE 2.000% 3/1.

Institutional Holders of AMPHASTAR PHARMACEUTICALS IN - NOTE 2.000% 3/1 across Reporting Periods

Period Principal Value Change Price (% of par) (Median) Investors
2025 Q4 $26,000 $24,048 -$3,322 92.58% 2
2025 Q3 $298,658,206 $271,682,316 +$15,400,429 90.9% 44
2025 Q2 $287,504,200 $250,404,674 -$1,633,019 86.66% 42
2025 Q1 $289,012,700 $257,820,283 -$20,287,313 88.89% 39
2024 Q4 $310,090,000 $290,929,251 -$11,267,553 93.11% 36
2024 Q3 $320,190,500 $339,259,650 +$336,118,248 105.6% 35